𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systemic juvenile rheumatoid arthritis: Cognitive function and social adjustment

✍ Scribed by Reinhold Feldmann; Josef Weglage; Johannes Roth; Dirk Foell; Michael Frosch


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
68 KB
Volume
58
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In contrast with other systemic rheumatic diseases in childhood, no systematic studies exist that focus on possible long‐term risks for central nervous system involvement in systemic juvenile rheumatoid arthritis (SJRA). We investigated 31 children and adolescents with SJRA, aged 6 to 24 years (mean, 12.5 years; standard deviation, 4.3 years), with mean disease duration of 6.2 years (standard deviation, 3.5 years; range, 0.6–14 years) for their cognitive and fine motor abilities. We also examined 31 matched healthy control subjects. In addition, parents assessed social activities and social and emotional problems in their children. Patients and control subjects performed within normal limits of intelligence quotient, memory and learning, attention, and fine motor scores. Less social activities were reported for patients. Patients and control subjects, however, had normal social and emotional problem scores. SJRA, although a burdensome chronic disease, is not associated with cognitive impairment or increased social and emotional problems. Cognitive performance and social adjustment of young patients with SJRA are not affected by disease activity and duration. Ann Neurol 2005;58:605–609


πŸ“œ SIMILAR VOLUMES


Decreased physical function in juvenile
✍ Miller, Michael L. ;Kress, Angela M. ;Berry, Carolyn A. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

To assess the extent of physical disability in juvenile rheumatoid arthritis (JRA), classified according to subtype, and whether synovitis or flexion contractures are present on examination. Methods. This retrospective study included 88 JRA patients and 50 controls without musculoskeletal disease.